Skip to content

Specimen collection study for diagnostic test development

Diagnostic advancement through specimen collection research and testing (DART)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN57139038
Enrollment
10000
Registered
2026-02-08
Start date
2025-10-09
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients presenting with symptoms of the areas of interest embolisms, infection or inflammation, cardiometabolic (includes heart failure, cardiovascular disease, myocardial infarction, diabetes) and renal cohorts Other

Interventions

Collection of venous and capillary blood samples from subjects with disease areas of interest (including but not limited to embolisms, infection or inflammation, cardiometabolic (including heart failu

Sponsors

JEMMDx Ltd
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. 18 years of age or over 2. Willing and able to provide written informed consent and comply with study procedures 3. Subjects attending a definitive care team with research capabilities which has been enrolled in this collection study 4. The subject must present as one of the following cohorts: Group A – Embolism Cohort: Subjects presenting with symptoms indicative of thromboembolic events Group B – Infection or Inflammation Cohort: Subjects presenting with symptoms indicative of infection or inflammatory disorders Group C – Cardiometabolic Cohort: Subjects presenting with symptoms indicative of heart conditions such as cardiovascular disease, heart failure or acute coronary syndrome, or diabetes Group D – Renal Cohort: Subjects presenting with symptoms indicative of renal disorders Group E – Other Cohort: Subjects who are not eligible for any other groups

Exclusion criteria

Exclusion criteria: 1. <18 years of age 2. Vulnerable populations deemed inappropriate for the study by the sites Principal Investigator 3. Subjects who have previously been enrolled in the study within the past 3 months and re-entry would breach the 24 ml and or 6 fingerstick maximums

Countries

Scotland, United Kingdom

Contacts

Public ContactJayne Ellis
jayne@jemmdx.com+44 (0)7572 749641

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026